$0.282
-0.041 (-14.47%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
EVGN Prediction & Forecast by Similar Chart Analysis
Alphio's EVGN stock price prediction model matches the current Evogene Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.28 (+0.02%). The 1-week path is $0.28 (-1.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Evogene Ltd Stock?
Evogene Ltd is not a good buy right now due to significant financial losses and poor performance metrics. The current price is $0.2819, with a 52-week high of $1.28, indicating a substantial decline of 76.21% over the past year. Additionally, the RSI is extremely low at 8.602, suggesting oversold conditions but also a lack of buying momentum. The company reported a net loss of $1.8 million in Q2 2026, which is a 62% improvement year-over-year, but still reflects ongoing financial struggles. The main risk is the proxy fight with shareholders, which could further destabilize the company's management and strategy.
EVGN stock price ended at $0.28 on Friday, after losing -14.47%
Evogene Ltd (EVGN) last closed at $0.2819, losing -14.47%. These facts feed the 1-day and 1-week EVGN price prediction above.
Analyst Consensus
Evogene Ltd (EVGN): 1 buy, 1 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Evogene Ltd (EVGN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches EVGN, ranked by similarity.
Seasonality analysis for EVGN
Historically the probability of a positive November return for EVGN is 0.00%. January offers the highest probability of a positive month at 16.39%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for EVGN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.09 | $1.49 | $1.93 | +428.61% |
| Dec 2026 | $0.96 | $1.31 | $1.65 | +364.79% |
In 2026, Evogene Ltd (EVGN) is projected to range from $0.96 to $1.93.
Evogene Ltd 2026 monthly forecast
In Nov 2026, Evogene Ltd is projected to average $1.49, with a low of $1.09 and high of $1.93.
In Dec 2026, Evogene Ltd is projected to average $1.31, with a low of $0.96 and high of $1.65.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.